Emily Boja

PhD

Silver Spring, MD, USA

About

Senior Scientist, Office of Chief Scientist

Office of Health Informatics, FDA

Dr. Boja leads the precisionFDA’s biomedical competitions around omics science, as well as outreach activities in building a community of scientists around the analysis of biological datasets to inform regulatory science and advance precision medicine. Prior to joining OHI, she was a Program Director at the Office of Cancer Clinical Proteomic Research, NCI, NIH, who provided scientific expertise and leadership in managing the Clinical Proteomic Tumor Analysis Consortium program.

scientific

Projects

Data

Specimen

Ongoing

Children's Brain Tumor Network Pediatric Brain Tumor Proteomics Pilot…

Pediatric brain tumors are the leading cause of disease related death in children. Major factors contributing to treatment failures for children with brain tumors include: i) the lack of comprehensive molecular description of the disease and an associated dearth of integration of the tumors’ biologi

…

Craniopharyngioma, Medulloblastoma, HGG, (AT/RT), LGG, Ependymoma, Ganglioglioma, DNET, Schwannoma

…

Adam Resnick

Children’s Hospital of Philadelphia

Philadelphia, PA, USA

research

Interests

Craniopharyngioma

Craniopharyngioma…

Childhood craniopharyngiomas are rare tumors usually found near the pituitary gland (a pea-sized organ at the bottom of the brain that controls other glands) and the hypothalamus (a small cone-shaped organ connected to the pituitary gland by nerves).Craniopharyngiomas are usually part solid mass and

…

129

Participants

Projects Supported

Medulloblastoma

Medulloblastoma…

Medulloblastomas comprises the vast majority of pediatric embryonal tumors and by definition arise in the posterior fossa, where they constitute approximately 40% of all posterior fossa tumors. Other forms of embryonal tumors each make up 2% or less of all childhood brain tumors.The clinical feature

…

443

Participants

Projects Supported